BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31939152)

  • 21. The Enzymatic Activity of APOBE3G Multimers.
    Pan Y; Zagorski K; Shlyakhtenko LS; Lyubchenko YL
    Sci Rep; 2018 Dec; 8(1):17953. PubMed ID: 30560880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA binding to APOBEC3G induces the disassembly of functional deaminase complexes by displacing single-stranded DNA substrates.
    Polevoda B; McDougall WM; Tun BN; Cheung M; Salter JD; Friedman AE; Smith HC
    Nucleic Acids Res; 2015 Oct; 43(19):9434-45. PubMed ID: 26424853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
    Maiti A; Myint W; Delviks-Frankenberry KA; Hou S; Kanai T; Balachandran V; Sierra Rodriguez C; Tripathi R; Kurt Yilmaz N; Pathak VK; Schiffer CA; Matsuo H
    J Mol Biol; 2020 Nov; 432(23):6042-6060. PubMed ID: 33098858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.
    Fukuda H; Li S; Sardo L; Smith JL; Yamashita K; Sarca AD; Shirakawa K; Standley DM; Takaori-Kondo A; Izumi T
    Front Cell Infect Microbiol; 2019; 9():129. PubMed ID: 31165049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
    Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
    J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Investigations on the Interactions between Cytidine Deaminase Human APOBEC3G and DNA.
    Yan X; Lan W; Wang C; Cao C
    Chem Asian J; 2019 Jul; 14(13):2235-2241. PubMed ID: 31116511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.
    Valera MS; de Armas-Rillo L; Barroso-González J; Ziglio S; Batisse J; Dubois N; Marrero-Hernández S; Borel S; García-Expósito L; Biard-Piechaczyk M; Paillart JC; Valenzuela-Fernández A
    Retrovirology; 2015 Jun; 12():53. PubMed ID: 26105074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atomic force microscopy studies of APOBEC3G oligomerization and dynamics.
    Shlyakhtenko LS; Lushnikov AY; Miyagi A; Li M; Harris RS; Lyubchenko YL
    J Struct Biol; 2013 Nov; 184(2):217-25. PubMed ID: 24055458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOBEC family proteins: novel antiviral innate immunity.
    Takaori-Kondo A
    Int J Hematol; 2006 Apr; 83(3):213-6. PubMed ID: 16720550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
    Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures of APOBEC3G N-domain alone and its complex with DNA.
    Xiao X; Li SX; Yang H; Chen XS
    Nat Commun; 2016 Aug; 7():12193. PubMed ID: 27480941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
    Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
    Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms.
    Okada A; Iwatani Y
    Front Microbiol; 2016; 7():2027. PubMed ID: 28066353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
    Bélanger K; Langlois MA
    Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV restriction factor APOBEC3G binds in multiple steps and conformations to search and deaminate single-stranded DNA.
    Morse M; Naufer MN; Feng Y; Chelico L; Rouzina I; Williams MC
    Elife; 2019 Dec; 8():. PubMed ID: 31850845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
    Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
    J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.